NEUREXAN gouttes fl 30 ml

7680612070016 CH-61207 20.01.1.
NEUREXAN gouttes fl 30 ml
NEUREXAN gouttes fl 30 ml
NEUREXAN gouttes fl 30 ml
1 / 3
google

Details

Product number
6120701
CPT
-
Packaging group
30
Unit
ml
Composition
passiflora incarnata (HAB) D2 0.6 mg, avena sativa (HAB) D2 0.6 mg, coffea arabica (HAB) D12 0.6 mg, zincum isovalerianicum (HAB) D4 (HAB 5a) 0.6 mg, ethanolum 96 per centum, aqua purificata, ad solutionem pro 1 g, corresp. 20 guttae, corresp. ethanolum 36 % V/V.

Articles (1)

Neurexan, Tropfen zum Einnehmen
Tropfen zum Einnehmen
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/07/2025
Patient information leaflet
Français
09/07/2025
Patient information leaflet
Italien
09/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
0.6 MG Substance Wirkstoff (Principe actif)
(N/A)
0.6 MG Substance Wirkstoff (Principe actif)
(N/A)
0.6 MG Substance Wirkstoff (Principe actif)
(N/A)
0.6 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK

Authorization holder

ebi-pharm ag

3038 Kirchlindach

Authorization information

Swissmedic authorization number
61207
Drug name
Neurexan, Tropfen zum Einnehmen
Galenic form
TROF
Authorization status
Z
Dispensation category
D
First authorization
22/12/2010
Authorization expiration date
31/12/9999
IT number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei Schlafstörungen und nervösen Unruhezuständen.

Packaging details

Description (FR)
NEUREXAN gouttes fl 30 ml
Description (DE)
NEUREXAN Tropfen Fl 30 ml
Market launch
22/12/2010
Narcotic (BTM)
No